MEDICSKIN (08307) announced its interim results for the six months ended September 30, 2025. The company recorded revenue of HK$22.774 million, a year-on-year increase of 1.97%. Profit attributable to owners of the company was HK$35,000, compared to a loss of HK$2.033 million in the same period last year, marking a turnaround from loss to profit. Earnings per share stood at HK$0.01 cent.

The company attributed the profit turnaround primarily to cost savings from reduced depreciation of right-of-use assets (due to lower rental expenses) and savings in employee costs, amounting to approximately HK$1 million each.